Advanced Search

 

Study ID Status Title Patient Level Data
115119 Completed A Double-Blind (sponsor unblind), Placebo Controlled, Randomised, Parallel Group Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of GSK2269557 Administered as a Dry Powder to COPD Patients and Assessment of Dose Response using Sputum Biomarkers
115123 Completed A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects with Generalized Myasthenia Gravis (MG)
115125 Completed A Phase Ib Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Activity of the Oral AKT Inhibitor GSK2110183 Administered in Combination with Bortezomib and Dexamethasone in Subjects with Relapsed/Refractory Multiple Myeloma
115131 Recruiting An Open Label Continuation Study of the Oral AKT Inhibitor GSK2110183 in Subjects with Solid Tumors and Hematologic Malignancies
115134 Completed A randomised, double-blind, placebo-controlled, cross-over study to evaluate the effect of treatment with repeat dose GSK2190915 as an add-on to current therapy on the percentage of neutrophils in induced sputum in asthmatic patients with elevated sputum neutrophils Study Listed on ClinicalStudyDataRequest.com
115148 Completed An open-label, single dose, randomized, two-period crossover study to investigate the bioavailability of a novel dosage form of dutasteride in healthy male subjects Study Listed on ClinicalStudyDataRequest.com
115150 Completed A 12-month, open label, randomised, effectiveness study to evaluate fluticasone furoate (FF, GW685698)/vilanterol (VI, GW642444) Inhalation Powder delivered once daily via a Novel Dry Powder Inhaler compared with usual maintenance therapy in subjects with Asthma
115151 Completed A 12-month, open label, randomised, effectiveness study to evaluate fluticasone furoate (FF, GW685698)/vilanterol (VI, GW642444) Inhalation Powder delivered once daily via a Novel Dry Powder Inhaler (NDPI) compared with the existing COPD maintenance therapy alone in subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
115152 Completed PGx397 whole genome sequencing of lapatinib concurrent ALT/TBL elevation and extreme ALT elevation cases
115158 Completed Immunogenicity and safety study of GSK Biologicals’ combined measles-mumps-rubella vaccine in subjects four to six years of age (209762)
115159 Completed PGx349 Exploratory pharmacogenetic analysis of lapatinib hepatotoxicity data – association analyses, genetic signal refinement, and HLA imputation analyses
115166 Completed A Randomized, double blind, parallel group, single center, adaptive phase I study to evaluate the safety, efficacy and dose responses of SB-751689 (ronacaleret; a calcium sensing receptor antagonist) for durations not to exceed 28 days, versusplacebo in healthy human volunteers.
115170 Completed Blinded, Re-adjudication of Mortality and Major Cardiovascular Endpoints (MACE) from the Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of glycaemia in Diabetes trial (RECORD)
115198 Completed A Two-Part Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Repeat IV Doses of GSK2140944 in Healthy Adult Subjects. Study Listed on ClinicalStudyDataRequest.com
115199 Completed A randomized, double-blind, placebo-controlled, four-way crossover study to evaluate and compare the pharmacodynamics and pharmacokinetics of fluticasone furoate /vilanterol in different dose combination (50/25mcg, 100/25mcg and 200/25mcg) after single and repeat dose administration from a novel dry powder device in healthy Chinese subjects Study Listed on ClinicalStudyDataRequest.com
115207 Completed A Single-Dose, Open-Label, Randomized, Two-Period Crossover Study to Demonstrate the Bioequivalence of Lamotrigine Dispersible/Chewable Tablets (5mg×5) and Lamotrigine Compressed Tablet (25mg) in Healthy Chinese Male Subjects. Study Listed on ClinicalStudyDataRequest.com
115214 Completed An open label, single-dose, fixed sequence, two treatment period study to assess the effect of haemodialysis on the pharmacokinetics of ezogabine/retigabine and the n-acetyl metabolite of ezogabine/retigabine (NAMR). Study Listed on ClinicalStudyDataRequest.com
115215 Completed An open-label, multi-centre, single arm study to evaluate the safety and efficacy of intravenous zanamivir in the treatment of hospitalized patients with confirmed influenza infection (NAI115215) Study Listed on ClinicalStudyDataRequest.com
115227 Completed A Meta-Analysis of the Cumulative Incidence of Hypertension in the first Month of Treatment with Pazopanib Across Three Renal Cell Carcinoma Studies: VEG102616, VEG105192, and VEG107769
115231 Completed Immunogenicity and safety study of GSK Biologicals’ combined measles-mumps-rubella vaccine in subjects seven years and older (209762)
115232 Recruiting PRINCIPAL: A Prospective Observational Study of Real World Treatment Patterns and Treatment Outcomes in Patients with Advanced or Metastatic Renal Cell Carcinoma Receiving Pazopanib
115241 Terminated A study to characterize the novel TSPO PET radioligand [18F]PBR111 as an in vivo marker of microglial activation in Multiple Sclerosis
115243 Completed An Open Label, Non-Randomized, Single dose, Mass Balance Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK2251052 Administered as a Single Intravenous Dose to Healthy Adult Subjects
115244 Terminated A study to evaluate the relative bioavailability of five different oral formulations of GSK2251052 and the multiple-dose, safety, tolerability, and pharmacokinetics of GSK2251052 with and without food in male and female, young and elderly healthy volunteers
115246 Completed A two part randomized, double-blind, placebo controlled study to investigate the effects of topical doses of SB705498 oncapsaicin, histamine, and cowhage responses in healthy volunteers. Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.